ホーム>Journal Club> Impact of Body Mass Index, central Adiposity, and Weight Loss on the Benefits of Trizepatide in HFpEF：The SUMMIT Trial ―チルゼパチドのHFpEFを有する肥満患者への有効性―
Impact of Body Mass Index, central Adiposity, and Weight Loss on the Benefits of Trizepatide in HFpEF：The SUMMIT Trial ―チルゼパチドのHFpEFを有する肥満患者への有効性―
2025/08/04
Impact of Body Mass Index, central Adiposity, and Weight Loss on the Benefits of Trizepatide in HFpEF：The SUMMIT Trial
